阿托伐他汀联合曲美他嗪治疗冠心病稳定性心绞痛的临床分析  

Clinical analysis on treating angina pectoris of coronary heart disease by atorvastatin and trimetazidine

作　　者：孙晶 

机构地区：[1]内蒙古自治区人民医院,内蒙古呼和浩特010010

出　　处：《世界最新医学信息文摘》2015年第36期5-6,共2页World Latest Medicine Information Electronic Version

摘　　要：目的分析阿托伐他汀联合曲美他嗪治疗冠心病稳定性心绞痛的临床疗效。方法选取2014年1月至2014年12月内蒙古自治区人民医院心内科收治的130例冠心病稳定性心绞痛患者为研究对象,将其随机分为观察组与对照组各65例。观察组给予阿托伐他汀联合曲美他嗪治疗,对照组仅给予阿托伐他汀治疗,比较两组患者的临床治疗效果。结果观察组心绞痛发作次数及持续时间等方面均少于对照组(P<0.05),有统计学意义。结论阿托伐他汀联合曲美他嗪治疗冠心病稳定性心绞痛的临床疗效显著,值得在临床上推广。Objective analyze clinical effects of treating angina pectoris of coronary heart disease by atorvastatin and trimetazidine. Method choose 130 case patients of angina pectoris of coronary heart disease received in our hospital as study object during Jan, 2014 and Dec, 2014, and divide them into observation group and control group randomly, and 65 in each group. Apply atorvastatin and trimetazidine for observation group, and atorvastatin only for control group, and compare clinical treating effects of both group’s patients. Result seizure frequency and duration of angina of observation group is less than control group（P〈0.05）, which shows statistics meaning. Conclusion treating angina pectoris of coronary heart disease by ator-vastatin and trimetazidine shows remarkable clinical effects and worthy of being spreaded clinically.

关 键 词：阿托伐他汀 曲美他嗪 冠心病稳定性心绞痛 疗效 

分 类 号：R972[医药卫生—药品]